Alnylam Pharmaceuticals Inc(ALNY)
237.55
Change: -12.57 (▼ -5.29%)
As of Wed 12/21/2022 12:50 AM% Of Value
Growth
Value Per Share
:
:
:
-636.55
71.31
-22.6500 (as of 20/12/2022)
Fundamentals Data
| Open | 234.00 | Dividend | 86 |
| Close Price | 237.55 | DivYield | 0 % |
| High | 239.52 | Growth | 351.4 M |
| Low | 233.535 | Growth% | 71.31 |
| P/e | -11.586 | Volume | 895,548.0 |
| P/b | -4.24 | Market Capital | 27.7 B |
| Highest High | Lowest Low | ||
| 50 Days Moving Average | 210.89 (as of 20/12/2022) | 50 Days Moving Average Percentage | 9.9035331311146 (as of 20/12/2022 |
| Industry: Major Pharmaceuticals |
Charts for balance Sheet:
Balance Sheet Table: last 5 years
Note: Numbers are estimated, Exact figures can be found in Annual Reports
| Type | Year1 / 2017 | Year2 / 2018 | Year3 / 2019 | Year4 / 2020 | Current Year / 2021 |
| Revenue | 89.9 M | 74.9 M | 219.7 M | 492.8 M | 844.2 M |
| Cap Spending | -104.2 M | -126.8 M | -140.1 M | -70.3 M | -76.3 M |
| Operating Expenses | 590.0 M | 887.7 M | 1.1 B | 1.2 B | 1.4 B |
| Operating Cash Flow | -500.0 M | -814.6 M | -939.4 M | -828.4 M | -708.6 M |
| Free Cash Flow | -486.9 M | -689.5 M | -418.5 M | -685.3 M | -718.0 M |
| Free Cash Flow Per Share | -5.378 | -6.855 | -3.831 | -5.96 | -6.062 |
| Total liabilities | 30.0 M | 30.0 M | 303.8 M | 521.1 M | 997.5 M |
| Total cash | 645.3 M | 420.1 M | 547.1 M | 496.5 M | 819.9 M |
| ROE% | -0.411 | -0.495 | -0.558 | -0.689 | -1.092 |
| Outstanding Shares | 99.8 M | 106.2 M | 112.5 M | 117.0 M | 120.2 M |
| P/E | -24.768 | -11.586 | -16.53 | -22.545 | -21.265 |
| P/S | 135.22 | 117.779 | 66.654 | 39.261 | 21.48 |
| Revenue USD | 89.9 M | 74.9 M | 219.7 M | 492.8 M | 844.2 M |
| NO REPORTS FOR THIS STOCK |
Latest Searches
| Stock | Close Price | %of value | Date |
|---|